{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:24:39Z","timestamp":1787635479202,"version":"build-2736575974"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"crossref","award":["2023SCUH0042"],"award-info":[{"award-number":["2023SCUH0042"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sichuan University Interdisciplinary Innovation Fund"},{"name":"Discipline excellence development 135 project of West China Hospital of Sichuan University","award":["2025HXBH070"],"award-info":[{"award-number":["2025HXBH070"]}]},{"DOI":"10.13039\/501100010822","name":"Chengdu Science and Technology Bureau","doi-asserted-by":"crossref","award":["2024-YF05-00636-SN"],"award-info":[{"award-number":["2024-YF05-00636-SN"]}],"id":[{"id":"10.13039\/501100010822","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40123-025-01280-2","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T15:39:43Z","timestamp":1763480383000},"page":"63-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Atropine-Loaded Contact Lens Sustained-Release Systems: A Narrative Review for the New Frontier for Myopia Management"],"prefix":"10.1007","volume":"15","author":[{"given":"Yuhang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0165-3607","authenticated-orcid":false,"given":"Xiaohang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2265-4625","authenticated-orcid":false,"given":"Longqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"3","key":"1280_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/OPX.0000000000002119","volume":"101","author":"MA Bullimore","year":"2024","unstructured":"Bullimore MA, Jong M, Brennan NA. Myopia control: seeing beyond efficacy. Optom Vis Sci. 2024;101(3):134\u201342.","journal-title":"Optom Vis Sci"},{"issue":"6","key":"1280_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjo.2024.100113","volume":"13","author":"IG Morgan","year":"2024","unstructured":"Morgan IG. Is there an impending epidemic of myopia in Southeast Asia? An appraisal of the evidence. Asia-Pac J Ophthalmol. 2024;13(6):100113.","journal-title":"Asia-Pac J Ophthalmol"},{"key":"1280_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2024-325427","author":"J Liang","year":"2024","unstructured":"Liang J, Pu Y, Chen J, Liu M, Ouyang B, Jin Z, et al. Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis. Br J Ophthalmol. 2024. https:\/\/doi.org\/10.1136\/bjo-2024-325427.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"1280_CR4","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036\u201342.","journal-title":"Ophthalmology"},{"issue":"3","key":"1280_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/bjo-2022-322285","volume":"108","author":"J Li","year":"2024","unstructured":"Li J, Dan YS, Chua SQ, Wong QY, Chong RS, Ang M, et al. Pathologic myopia in highly myopic patients with high axial anisomyopia. Br J Ophthalmol. 2024;108(3):411\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1280_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jamaophthalmol.2021.5347","volume":"140","author":"DSC Ng","year":"2022","unstructured":"Ng DSC, Lai TYY. Insights into the global epidemic of high myopia and its implications. JAMA Ophthalmol. 2022;140(2):123\u20134.","journal-title":"JAMA Ophthalmol"},{"key":"1280_CR7","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.12.11003","volume":"12","author":"Y Ma","year":"2022","unstructured":"Ma Y, Wen Y, Zhong H, Lin S, Liang L, Yang Y, et al. Healthcare utilization and economic burden of myopia in urban China: a nationwide cost-of-illness study. J Glob Health. 2022;12:11003.","journal-title":"J Glob Health"},{"issue":"3","key":"1280_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ophtha.2018.10.029","volume":"126","author":"KS Naidoo","year":"2019","unstructured":"Naidoo KS, Fricke TR, Frick KD, Jong M, Naduvilath TJ, Resnikoff S, et al. Potential lost productivity resulting from the global burden of myopia: systematic review, meta-analysis, and modeling. Ophthalmology. 2019;126(3):338\u201346.","journal-title":"Ophthalmology"},{"issue":"6","key":"1280_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.64.6.6","volume":"64","author":"JS Wolffsohn","year":"2023","unstructured":"Wolffsohn JS, Whayeb Y, Logan NS, Weng R. IMI-global trends in myopia management attitudes and strategies in clinical practice-2022 update. Invest Ophthalmol Vis Sci. 2023;64(6):6.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1280_CR10","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.6.7","volume":"64","author":"P Sankaridurg","year":"2023","unstructured":"Sankaridurg P, Berntsen DA, Bullimore MA, Cho P, Flitcroft I, Gawne TJ, et al. IMI 2023 digest. Invest Ophthalmol Vis Sci. 2023;64(6):7.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"1280_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.64.6.3","volume":"64","author":"I Flitcroft","year":"2023","unstructured":"Flitcroft I, Ainsworth J, Chia A, Cotter S, Harb E, Jin ZB, et al. IMI-management and investigation of high myopia in infants and young children. Invest Ophthalmol Vis Sci. 2023;64(6):3.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1280_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.62.5.3","volume":"62","author":"IG Morgan","year":"2021","unstructured":"Morgan IG, Wu PC, Ostrin LA, Tideman JWL, Yam JC, Lan W, et al. IMI risk factors for myopia. Invest Ophthalmol Vis Sci. 2021;62(5):3.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1280_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/opo.13244","volume":"44","author":"MC Marcell\u00e1n Vidosa","year":"2024","unstructured":"Marcell\u00e1n Vidosa MC, Rem\u00f3n L, \u00c1vila FJ. Peripheral refraction under different levels of illuminance. Ophthalm Physiol Opt. 2024;44(1):191\u20138.","journal-title":"Ophthalm Physiol Opt"},{"issue":"1","key":"1280_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3341\/kjo.2022.0125","volume":"37","author":"N Erdinest","year":"2023","unstructured":"Erdinest N, London N, Lavy I, Berkow D, Landau D, Morad Y, et al. Peripheral defocus and myopia management: a mini-review. Korean Journal of Ophthalmology\u202f: KJO. 2023;37(1):70\u201381.","journal-title":"Korean Journal of Ophthalmology : KJO"},{"key":"1280_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/opo.13097","author":"DA Atchison","year":"2023","unstructured":"Atchison DA, Rozema JJ. Technical notes on peripheral refraction, peripheral eye length and retinal shape determination. Ophthalm Physiol Opt. 2023. https:\/\/doi.org\/10.1111\/opo.13097.","journal-title":"Ophthalm Physiol Opt"},{"issue":"7","key":"1280_CR16","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1167\/iovs.17-22562","volume":"59","author":"BJ Carr","year":"2018","unstructured":"Carr BJ, Mihara K, Ramachandran R, Saifeddine M, Nathanson NM, Stell WK, et al. Myopia-inhibiting concentrations of muscarinic receptor antagonists block activation of alpha2A-adrenoceptors in vitro. Investigative Ophthalmology & Visual Science. 2018;59(7):2778.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"5","key":"1280_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/OPX.0000000000002249","volume":"102","author":"D Horn","year":"2025","unstructured":"Horn D, Salzano AD, Jenewein EC, Weise KK, Schaeffel F, Mathis U, et al. Topical review: Potential mechanisms of atropine for myopia control. Optom Vis Sci. 2025;102(5):260\u201370.","journal-title":"Optom Vis Sci"},{"key":"1280_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115542","volume":"167","author":"K Thomson","year":"2023","unstructured":"Thomson K, Karouta C, Weber D, Hoffmann N, Morgan I, Kelly T, et al. The role of the serotonergic system in atropine\u2019s anti-myopic effects. Biomed Pharmacother. 2023;167:115542.","journal-title":"Biomed Pharmacother"},{"key":"1280_CR19","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_2378_23","author":"J Jethani","year":"2024","unstructured":"Jethani J. Effect of defocus incorporated multiple segments lenses on halting myopia progression not responding to low-concentration atropine (0.01%) eye drops. Indian J Ophthalmol. 2024. https:\/\/doi.org\/10.4103\/IJO.IJO_2378_23.","journal-title":"Indian J Ophthalmol"},{"issue":"12","key":"1280_CR20","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/bjo-2022-321272","volume":"107","author":"S Xu","year":"2023","unstructured":"Xu S, Li Z, Zhao W, Zheng B, Jiang J, Ye G, et al. Effect of atropine, orthokeratology and combined treatments for myopia control: a 2-year stratified randomised clinical trial. Br J Ophthalmol. 2023;107(12):1812\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"1280_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2023.102094","volume":"47","author":"J Zhang","year":"2024","unstructured":"Zhang J, Li Z, Cheng Z, Wang T, Shi W. Comparison of the clinical efficacy of orthokeratology and 0.01% atropine for retardation of myopia progression in myopic children. Contact Lens Anterior Eye. 2024;47(1):102094.","journal-title":"Contact Lens Anterior Eye"},{"issue":"5","key":"1280_CR22","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/opo.13021","volume":"42","author":"D Kaphle","year":"2022","unstructured":"Kaphle D, Varnas SR, Schmid KL, Suheimat M, Leube A, Atchison DA. Accommodation lags are higher in myopia than in emmetropia: Measurement methods and metrics matter. Ophthalm Physiol Optics Journal of the Br Coll Ophthalm Opt (Optometrists). 2022;42(5):1103-1114J.","journal-title":"Ophthalm Physiol Optics Journal of the Br Coll Ophthalm Opt (Optometrists)"},{"issue":"6","key":"1280_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/iovs.63.6.24","volume":"63","author":"D Kaphle","year":"2022","unstructured":"Kaphle D, Schmid KL, Davies LN, Suheimat M, Atchison DA. Ciliary muscle dimension changes with accommodation vary in myopia and emmetropia. Invest Ophthalmol Vis Sci. 2022;63(6):24.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1280_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1167\/iovs.05-0888","volume":"47","author":"DO Mutti","year":"2006","unstructured":"Mutti DO, Mitchell GL, Hayes JR, Jones LA, Moeschberger ML, Cotter SA, et al. Accommodative lag before and after the onset of myopia. Invest Ophthalmol Vis Sci. 2006;47(3):837\u201346.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1280_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7549851","volume":"2022","author":"X Chen","year":"2022","unstructured":"Chen X, Jiang Y, Fan Q, Li L, Lu W, Wang Y. Association of axial length and refraction with near horizontal heterophoria in Chinese children: an observational cross-sectional study. J Ophthalmol. 2022;2022:7549851.","journal-title":"J Ophthalmol"},{"issue":"3","key":"1280_CR26","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1167\/iovs.16-19093","volume":"58","author":"DO Mutti","year":"2017","unstructured":"Mutti DO, Mitchell GL, Jones-Jordan LA, Cotter SA, Kleinstein RN, Manny RE, et al. The response AC\/A ratio before and after the onset of myopia. Invest Ophthalmol Vis Sci. 2017;58(3):1594\u2013602.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"1280_CR27","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/OPX.0000000000000040","volume":"90","author":"LN Thibos","year":"2013","unstructured":"Thibos LN, Bradley A, Liu T, L\u00f3pez-Gil N. Spherical aberration and the sign of defocus. Optom Vis Sci. 2013;90(11):1284\u201391.","journal-title":"Optom Vis Sci"},{"issue":"9","key":"1280_CR28","first-page":"2469","volume":"41","author":"DO Mutti","year":"2000","unstructured":"Mutti DO, Jones LA, Moeschberger ML, Zadnik K. AC\/A ratio, age, and refractive error in children. Invest Ophthalmol Vis Sci. 2000;41(9):2469\u201378.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"1280_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/00006324-199102000-00005","volume":"68","author":"DA Goss","year":"1991","unstructured":"Goss DA. Clinical accommodation and heterophoria findings preceding juvenile onset of myopia. Optom Vis Sci. 1991;68(2):110\u20136.","journal-title":"Optom Vis Sci"},{"issue":"1","key":"1280_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2020-000628","volume":"6","author":"YL Wong","year":"2021","unstructured":"Wong YL, Yuan Y, Su B, Tufail S, Ding Y, Ye Y, et al. Prediction of myopia onset with refractive error measured using non-cycloplegic subjective refraction: the WEPrOM study. BMJ Open Ophthalmol. 2021;6(1):e000628.","journal-title":"BMJ Open Ophthalmol"},{"issue":"6","key":"1280_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/iovs.64.6.2","volume":"64","author":"MA Bullimore","year":"2023","unstructured":"Bullimore MA, Lee SS, Schmid KL, Rozema JJ, Leveziel N, Mallen EAH, et al. IMI-onset and progression of myopia in young adults. Invest Ophthalmol Vis Sci. 2023;64(6):2.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"1280_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134514","volume":"10","author":"SM Li","year":"2015","unstructured":"Li SM, Li SY, Kang MT, Zhou Y, Liu LR, Li H, et al. Near work related parameters and myopia in Chinese children: the Anyang Childhood Eye Study. PLoS ONE. 2015;10(8):e0134514.","journal-title":"PLoS ONE"},{"issue":"8","key":"1280_CR33","first-page":"891","volume":"3","author":"RH Bedrossian","year":"1971","unstructured":"Bedrossian RH. The effect of atropine on myopia. Ann Ophthalmol. 1971;3(8):891\u20137.","journal-title":"Ann Ophthalmol"},{"key":"1280_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2025.108656","volume":"234","author":"JT Lloyd","year":"2025","unstructured":"Lloyd JT, Collins AV, Phillips JR, Acosta ML. Atropine restores retinal glutamate \/ \u03b3-aminobutyric acid levels in vitro in an experimental chick model of myopia. Vis Res. 2025;234:108656.","journal-title":"Vis Res"},{"issue":"30","key":"1280_CR35","doi-asserted-by":"publisher","first-page":"E7091","DOI":"10.1073\/pnas.1721443115","volume":"115","author":"H Wu","year":"2018","unstructured":"Wu H, Chen W, Zhao F, Zhou Q, Reinach PS, Deng L, et al. Scleral hypoxia is a target for myopia control. Proc Natl Acad Sci USA. 2018;115(30):E7091\u2013100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1280_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102878","volume":"57","author":"F Zhao","year":"2020","unstructured":"Zhao F, Zhang D, Zhou Q, Zhao F, He M, Yang Z, et al. Scleral HIF-1\u03b1 is a prominent regulatory candidate for genetic and environmental interactions in human myopia pathogenesis. EBioMedicine. 2020;57:102878.","journal-title":"EBioMedicine"},{"issue":"4","key":"1280_CR37","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s11010-021-04305-z","volume":"477","author":"Y Ren","year":"2022","unstructured":"Ren Y, Yang X, Luo Z, Wu J, Lin H. HIF-1\u03b1 aggravates pathologic myopia through the miR-150-5p\/LAMA4\/p38 MAPK signaling axis. Mol Cell Biochem. 2022;477(4):1065\u201374.","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"1280_CR38","first-page":"2541","volume":"22","author":"YX Liu","year":"2018","unstructured":"Liu YX, Sun Y. MMP-2 participates in the sclera of guinea pig with form-deprivation myopia via IGF-1\/STAT3 pathway. Eur Rev Med Pharmacol Sci. 2018;22(9):2541\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"1280_CR39","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/opo.12696","volume":"40","author":"X Ding","year":"2020","unstructured":"Ding X, Fu D, Ge S, Guan Q, Chen M, Yu Z. DNA methylation and mRNA expression of IGF-1 and MMP-2 after form-deprivation myopia in guinea pigs. Ophthalmic Physiol Opt. 2020;40(4):491\u2013501.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"3","key":"1280_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166981","volume":"1870","author":"WQ Shi","year":"2024","unstructured":"Shi WQ, Li T, Liang R, Li B, Zhou X. Targeting scleral remodeling and myopia development in form deprivation myopia through inhibition of EFEMP1 expression. Biochim Biophys Acta. 2024;1870(3):166981.","journal-title":"Biochim Biophys Acta"},{"key":"1280_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2022.108055","volume":"198","author":"Q Li","year":"2022","unstructured":"Li Q, Fang F. Contribution of the retinal contour to the peripheral optics of human eye. Vis Res. 2022;198:108055.","journal-title":"Vis Res"},{"issue":"1","key":"1280_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/cxo.12991","volume":"103","author":"R Chakraborty","year":"2020","unstructured":"Chakraborty R, Ostrin LA, Benavente-Perez A, Verkicharla PK. Optical mechanisms regulating emmetropisation and refractive errors: evidence from animal models. Clin Exp Optom. 2020;103(1):55\u201367.","journal-title":"Clin Exp Optom"},{"key":"1280_CR43","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000001214","author":"R Zhang","year":"2025","unstructured":"Zhang R, Zhou Y, Ou Y, Chin MP, Li J, Jhanji V, et al. Comparison of the corneal high-order aberration and relative corneal refractive power distribution induced by different orthokeratology lenses designs. Eye Contact Lens. 2025. https:\/\/doi.org\/10.1097\/ICL.0000000000001214.","journal-title":"Eye Contact Lens"},{"issue":"1","key":"1280_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1600-0420.2006.00757.x","volume":"85","author":"LE de Castro","year":"2007","unstructured":"de Castro LE, Sandoval HP, Bartholomew LR, Vroman DT, Solomon KD. High-order aberrations and preoperative associated factors. Acta Ophthalmol Scand. 2007;85(1):106\u201310.","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"1280_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-023-00339-0","volume":"10","author":"Q Tan","year":"2023","unstructured":"Tan Q, Cho P, Ng ALK, Cheng GPM, Woo VCP, Vincent SJ. Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine. Eye Vis (Lond). 2023;10(1):21.","journal-title":"Eye Vis (Lond)"},{"issue":"1","key":"1280_CR46","volume":"7","author":"J Gomes","year":"2023","unstructured":"Gomes J, Sapkota K, Franco S. Central and peripheral ocular high-order aberrations and their relationship with accommodation and refractive error: a review. Vision (Basel, Switzerland). 2023;7(1):19.","journal-title":"Vision (Basel, Switzerland)"},{"issue":"1","key":"1280_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ophtha.2012.07.057","volume":"120","author":"T Hiraoka","year":"2013","unstructured":"Hiraoka T, Miyata K, Nakamura Y, Miyai T, Ogata M, Okamoto F, et al. Influences of cycloplegia with topical atropine on ocular higher-order aberrations. Ophthalmology. 2013;120(1):8\u201313.","journal-title":"Ophthalmology"},{"issue":"10","key":"1280_CR48","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.4103\/ijo.IJO_1728_21","volume":"69","author":"J Jethani","year":"2021","unstructured":"Jethani J, Kamat A, Jaiswal J. Effect of low-concentration atropine (0.01%) eye drops on higher-order aberrations in myopic children. Indian J Ophthalmol. 2021;69(10):2898.","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"1280_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2024.100672","volume":"5","author":"JS Wolffsohn","year":"2025","unstructured":"Wolffsohn JS, Gifford KL. Optical strategy utilizing contrast modulation to slow myopia. Ophthalmology Science. 2025;5(4):100672.","journal-title":"Ophthalmology Science"},{"issue":"3","key":"1280_CR50","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.6.3.2","volume":"6","author":"SH Greenwald","year":"2017","unstructured":"Greenwald SH, Kuchenbecker JA, Rowlan JS, Neitz J, Neitz M. Role of a dual splicing and amino acid code in myopia, cone dysfunction and cone dystrophy associated with L\/M opsin interchange mutations. Transl Vis Sci Technol. 2017;6(3):2.","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"1280_CR51","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/archopht.122.6.897","volume":"122","author":"TL Young","year":"2004","unstructured":"Young TL, Deeb SS, Ronan SM, Dewan AT, Alvear AB, Scavello GS, et al. X-linked high myopia associated with cone dysfunction. Arch Ophthalmol (Chicago, Ill\u202f: 1960). 2004;122(6):897\u2013908.","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"key":"1280_CR52","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cobeha.2019.05.004","volume":"30","author":"M Neitz","year":"2019","unstructured":"Neitz M, Patterson SS, Neitz J. Photopigment genes, cones, and color update: disrupting the splicing code causes a diverse array of vision disorders. Curr Opin Behav Sci. 2019;30:60\u20136.","journal-title":"Curr Opin Behav Sci"},{"key":"1280_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/genes13060942","author":"M Neitz","year":"2022","unstructured":"Neitz M, Wagner-Schuman M, Rowlan JS, Kuchenbecker JA, Neitz J. Insight from OPN1LW gene haplotypes into the cause and prevention of myopia. Genes. 2022. https:\/\/doi.org\/10.3390\/genes13060942.","journal-title":"Genes"},{"issue":"10","key":"1280_CR54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1167\/tvst.13.10.42","volume":"13","author":"J Neitz","year":"2024","unstructured":"Neitz J, Neitz M. Diffusion optics technology (DOT): a myopia control spectacle lens based on contrast theory. Transl Vis Sci Technol. 2024;13(10):42.","journal-title":"Transl Vis Sci Technol"},{"issue":"11","key":"1280_CR55","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1136\/bjo-2021-321005","volume":"107","author":"J Rappon","year":"2023","unstructured":"Rappon J, Chung C, Young G, Hunt C, Neitz J, Neitz M, et al. Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). Br J Ophthalmol. 2023;107(11):1709\u201315.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1280_CR56","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1073\/pnas.86.2.704","volume":"86","author":"RA Stone","year":"1989","unstructured":"Stone RA, Lin T, Laties AM, Iuvone PM. Retinal dopamine and form-deprivation myopia. Proc Natl Acad Sci U S A. 1989;86(2):704\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"48","key":"1280_CR57","doi-asserted-by":"publisher","first-page":"8231","DOI":"10.1523\/JNEUROSCI.1196-23.2023","volume":"43","author":"Z Shu","year":"2023","unstructured":"Shu Z, Chen K, Wang Q, Wu H, Zhu Y, Tian R, et al. The role of retinal dopamine D1 receptors in ocular growth and myopia development in mice. J Neurosci. 2023;43(48):8231\u201342.","journal-title":"J Neurosci"},{"issue":"1","key":"1280_CR58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/iovs.63.1.24","volume":"63","author":"F Huang","year":"2022","unstructured":"Huang F, Shu Z, Huang Q, Chen K, Yan W, Wu W, et al. Retinal dopamine D2 receptors participate in the development of myopia in mice. Invest Ophthalmol Vis Sci. 2022;63(1):24.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1280_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094989","author":"Y Ruan","year":"2021","unstructured":"Ruan Y, Patzak A, Pfeiffer N, Gericke A. Muscarinic acetylcholine receptors in the retina-therapeutic implications. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22094989.","journal-title":"Int J Mol Sci"},{"key":"1280_CR60","first-page":"680","volume":"17","author":"VA Barathi","year":"2011","unstructured":"Barathi VA, Beuerman RW. Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: Prior to and after induction of experimental myopia with atropine treatment. Mol Vis. 2011;17:680\u201392.","journal-title":"Mol Vis"},{"key":"1280_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.814814","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Bian JF, Lu DQ, To CH, Lam CS, Li KK, et al. Alteration of EIF2 signaling, glycolysis, and dopamine secretion in form-deprived myopia in response to 1% atropine treatment: evidence from interactive iTRAQ-MS and SWATH-MS proteomics using a guinea pig model. Front Pharmacol. 2022;13:814814.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1280_CR62","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1167\/iovs.02-0796","volume":"44","author":"WA Luft","year":"2003","unstructured":"Luft WA, Ming Y, Stell WK. Variable effects of previously untested muscarinic receptor antagonists on experimental myopia. Invest Ophthalmol Vis Sci. 2003;44(3):1330\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1280_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/biom13030434","author":"H Liu","year":"2023","unstructured":"Liu H, Schaeffel F, Yang Z, Feldkaemper MP. GABA(B) receptor activation affects eye growth in chickens with visually induced refractive errors. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13030434.","journal-title":"Biomolecules"},{"issue":"11","key":"1280_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1167\/iovs.63.11.10","volume":"63","author":"L Jiang","year":"2022","unstructured":"Jiang L, Liu X, Zhou L, Busoy JMF, Khine MT, Dan YS, et al. Choroidal thickness in early postnatal Guinea pigs predicts subsequent naturally occurring and form-deprivation myopia. Invest Ophthalmol Vis Sci. 2022;63(11):10.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1280_CR65","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.exer.2014.07.022","volume":"127","author":"U Mathis","year":"2014","unstructured":"Mathis U, Ziemssen F, Schaeffel F. Effects of a human VEGF antibody (bevacizumab) on deprivation myopia and choroidal thickness in the chicken. Exp Eye Res. 2014;127:161\u20139.","journal-title":"Exp Eye Res"},{"issue":"9","key":"1280_CR66","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1167\/iovs.07-0176","volume":"48","author":"KH Huemer","year":"2007","unstructured":"Huemer KH, Garhofer G, Aggermann T, Kolodjaschna J, Schmetterer L, Fuchsj\u00e4ger-Mayrl G. Role of nitric oxide in choroidal blood flow regulation during light\/dark transitions. Invest Ophthalmol Vis Sci. 2007;48(9):4215\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"1280_CR67","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.1167\/iovs.13-11708","volume":"55","author":"RS Ashby","year":"2014","unstructured":"Ashby RS, Zeng G, Leotta AJ, Tse DY, McFadden SA. Egr-1 mRNA expression is a marker for the direction of mammalian ocular growth. Invest Ophthalmol Vis Sci. 2014;55(9):5911\u201321.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"1280_CR68","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.7150\/ijms.94826","volume":"21","author":"J Xin","year":"2024","unstructured":"Xin J, Bao B, Liu J, Ma Z, Zhang M, Bi H, et al. Crosstalk between myopia and inflammation: a mini review. Int J Med Sci. 2024;21(9):1589\u2013603.","journal-title":"Int J Med Sci"},{"issue":"1","key":"1280_CR69","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1038\/s41467-021-22041-2","volume":"12","author":"X Zhu","year":"2021","unstructured":"Zhu X, Du Y, Li D, Xu J, Wu Q, He W, et al. Aberrant TGF-\u03b21 signaling activation by MAF underlies pathological lens growth in high myopia. Nat Commun. 2021;12(1):2102.","journal-title":"Nat Commun"},{"key":"1280_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242316928","author":"W Zhou","year":"2023","unstructured":"Zhou W, Jiang Z, Yi Z, Ouyang J, Li X, Zhang Q, et al. Defect of TIMP4 is associated with high myopia and participates in rat ocular development in a dose-dependent manner. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242316928.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1280_CR71","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1136\/bjo-2023-323764","volume":"108","author":"S Xu","year":"2024","unstructured":"Xu S, Wang M, Lin S, Jiang J, Yu M, Tang X, et al. Long-term effect of orthokeratology on choroidal thickness and choroidal contour in myopic children. Br J Ophthalmol. 2024;108(8):1067\u201374.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"1280_CR72","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/02713683.2024.2310618","volume":"49","author":"J Xiao","year":"2024","unstructured":"Xiao J, Pan X, Hou C, Wang Q. Changes in subfoveal choroidal thickness after orthokeratology in myopic children: a systematic review and meta-analysis. Curr Eye Res. 2024;49(7):683\u201390.","journal-title":"Curr Eye Res"},{"issue":"3","key":"1280_CR73","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/JCMA.0000000000000676","volume":"85","author":"CC Hsu","year":"2022","unstructured":"Hsu CC, Kuo YS, Lin PY, Chen KH. Overnight orthokeratology-associated Acanthamoeba keratitis at a tertiary referral hospital in Taiwan: a retrospective case-control study. J Chin Med Assoc. 2022;85(3):381\u20137.","journal-title":"J Chin Med Assoc"},{"issue":"2","key":"1280_CR74","doi-asserted-by":"publisher","first-page":"198","DOI":"10.7150\/ijms.30118","volume":"16","author":"Q Zhu","year":"2019","unstructured":"Zhu Q, Liu Y, Tighe S, Zhu Y, Su X, Lu F, et al. Retardation of myopia progression by multifocal soft contact lenses. Int J Med Sci. 2019;16(2):198\u2013202.","journal-title":"Int J Med Sci"},{"issue":"4","key":"1280_CR75","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ophtha.2024.09.031","volume":"132","author":"KM Cavuoto","year":"2025","unstructured":"Cavuoto KM, Trivedi RH, Prakalapakorn SG, Oatts JT, Nallasamy S, Morrison DG, et al. Multifocal soft contact lenses for the treatment of myopia progression in children: a report by the American Academy of Ophthalmology. Ophthalmology. 2025;132(4):495\u2013503.","journal-title":"Ophthalmology"},{"issue":"4","key":"1280_CR76","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/OPX.0000000000001874","volume":"99","author":"AN Nti","year":"2022","unstructured":"Nti AN, Gregory HR, Ritchey ER, Wolffsohn JS, Berntsen DA. Contrast sensitivity with center-distance multifocal soft contact lenses. Optom Vis Sci. 2022;99(4):342\u20139.","journal-title":"Optom Vis Sci"},{"key":"1280_CR77","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ajo.2024.08.020","volume":"269","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zeng L, Gu D, Wang B, Kang P, Watt K, et al. Spectacle lenses with highly aspherical lenslets for slowing axial elongation and refractive change in low-hyperopic Chinese children: a randomized controlled trial. Am J Ophthalmol. 2025;269:60\u20138.","journal-title":"Am J Ophthalmol"},{"key":"1280_CR78","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2147\/OPTH.S453731","volume":"18","author":"J Ma","year":"2024","unstructured":"Ma J, Yang X, Liu Z, Fu H, Fan S, Wang K, et al. The impact of vergence dysfunction on myopia control in children wearing defocus spectacle lenses. Clin Ophthalmol (Auckland, NZ). 2024;18:799\u2013807.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"8","key":"1280_CR79","first-page":"1110","volume":"106","author":"CS Lam","year":"2022","unstructured":"Lam CS, Tang WC, Lee PH, Zhang HY, Qi H, Hasegawa K, et al. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br J Ophthalmol. 2022;106(8):1110\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"1280_CR80","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s41433-024-02987-5","volume":"38","author":"T Tang","year":"2024","unstructured":"Tang T, Lu Y, Li X, Zhao H, Wang K, Li Y, et al. Comparison of the long-term effects of atropine in combination with orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents. Eye (Lond). 2024;38(9):1660\u20137.","journal-title":"Eye (Lond)"},{"issue":"1","key":"1280_CR81","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ophtha.2004.06.038","volume":"112","author":"DT Tan","year":"2005","unstructured":"Tan DT, Lam DS, Chua WH, Shu-Ping DF, Crockett RS. One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia. Ophthalmology. 2005;112(1):84\u201391.","journal-title":"Ophthalmology"},{"issue":"6","key":"1280_CR82","doi-asserted-by":"publisher","first-page":"969","DOI":"10.18240\/ijo.2023.06.21","volume":"16","author":"L Lai","year":"2023","unstructured":"Lai L, Trier K, Cui DM. Role of 7-methylxanthine in myopia prevention and control: a mini-review. Int J Ophthalmol. 2023;16(6):969\u201376.","journal-title":"Int J Ophthalmol"},{"issue":"2\u20134","key":"1280_CR83","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12177-008-9013-3","volume":"1","author":"K Trier","year":"2008","unstructured":"Trier K, Munk Ribel-Madsen S, Cui D, Br\u00f8gger Christensen S. Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study. J Ocul Biol Dis Infor. 2008;1(2\u20134):85\u201393.","journal-title":"J Ocul Biol Dis Infor"},{"key":"1280_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.03.013","author":"XJ Zhang","year":"2024","unstructured":"Zhang XJ, Zhang Y, Yip BHK, Kam KW, Tang F, Ling X, et al. Five-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 4 report. Ophthalmology. 2024. https:\/\/doi.org\/10.1016\/j.ophtha.2024.03.013.","journal-title":"Ophthalmology"},{"issue":"4","key":"1280_CR85","first-page":"588","volume":"108","author":"R Saxena","year":"2024","unstructured":"Saxena R, Gupta V, Dhiman R, Joseph E, Agarkar S, Neena R, et al. Low-dose atropine 0.01% for the treatment of childhood myopia: a pan-India multicentric retrospective study. Br J Ophthalmol. 2024;108(4):588\u201392.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"1280_CR86","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.40986","volume":"6","author":"S Agyekum","year":"2023","unstructured":"Agyekum S, Chan PP, Adjei PE, Zhang Y, Huo Z, Yip BHK, et al. Cost-effectiveness analysis of myopia progression interventions in children. JAMA Netw Open. 2023;6(11):e2340986.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"1280_CR87","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/bjophthalmol-2021-320318","volume":"107","author":"TR Fricke","year":"2023","unstructured":"Fricke TR, Sankaridurg P, Naduvilath T, Resnikoff S, Tahhan N, He M, et al. Establishing a method to estimate the effect of antimyopia management options on lifetime cost of myopia. Br J Ophthalmol. 2023;107(8):1043\u201350.","journal-title":"Br J Ophthalmol"},{"key":"1280_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124294","volume":"660","author":"F Li","year":"2024","unstructured":"Li F, Ye X, Li M, Nie Q, Wang H, Zhang G, et al. Enhanced ophthalmic bioavailability and stability of atropine sulfate via sustained release particles using polystyrene sulfonate resin. Int J Pharm. 2024;660:124294.","journal-title":"Int J Pharm"},{"key":"1280_CR89","doi-asserted-by":"publisher","first-page":"14837","DOI":"10.1038\/ncomms14837","volume":"8","author":"JG Ghosh","year":"2017","unstructured":"Ghosh JG, Nguyen AA, Bigelow CE, Poor S, Qiu Y, Rangaswamy N, et al. Long-acting protein drugs for the treatment of ocular diseases. Nat Commun. 2017;8:14837.","journal-title":"Nat Commun"},{"issue":"4","key":"1280_CR90","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40123-019-00217-w","volume":"8","author":"GL Larkin","year":"2019","unstructured":"Larkin GL, Tahir A, Epley KD, Beauchamp CL, Tong JT, Clark RA. Atropine 0.01% eye drops for myopia control in American children: a multiethnic sample across three US sites. Ophthalmol Ther. 2019;8(4):589\u201398.","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"1280_CR91","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ophtha.2008.10.020","volume":"116","author":"L Tong","year":"2009","unstructured":"Tong L, Huang XL, Koh AL, Zhang X, Tan DT, Chua WH. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Ophthalmology. 2009;116(3):572\u20139.","journal-title":"Ophthalmology"},{"issue":"2","key":"1280_CR92","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology. 2012;119(2):347\u201354.","journal-title":"Ophthalmology"},{"key":"1280_CR93","doi-asserted-by":"publisher","first-page":"1343698","DOI":"10.3389\/fphar.2024.1343698","volume":"15","author":"SH Lee","year":"2024","unstructured":"Lee SH, Tsai PC, Chiu YC, Wang JH, Chiu CJ. Myopia progression after cessation of atropine in children: a systematic review and meta-analysis. Front Pharmacol. 2024;15:1343698.","journal-title":"Front Pharmacol"},{"key":"1280_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2025.114293","volume":"239","author":"I Garc\u00eda-del-Valle","year":"2025","unstructured":"Garc\u00eda-del-Valle I, Vivero-Lopez M, Concheiro A, Alvarez-Lorenzo C. Contact lens-based atropine delivery systems for myopia management: design and in vitro-in vivo evaluation. Eur Polym J. 2025;239:114293.","journal-title":"Eur Polym J"},{"issue":"8","key":"1280_CR95","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/17425247.2020.1787983","volume":"17","author":"OL Lanier","year":"2020","unstructured":"Lanier OL, Christopher KG, Macoon RM, Yu Y, Sekar P, Chauhan A. Commercialization challenges for drug-eluting contact lenses. Expert Opin Drug Deliv. 2020;17(8):1133\u201349.","journal-title":"Expert Opin Drug Deliv"},{"issue":"5","key":"1280_CR96","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0161-6420(79)35455-0","volume":"86","author":"RH Bedrossian","year":"1979","unstructured":"Bedrossian RH. The effect of atropine on myopia. Ophthalmology. 1979;86(5):713\u20139.","journal-title":"Ophthalmology"},{"issue":"12","key":"1280_CR97","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","volume":"113","author":"WH Chua","year":"2006","unstructured":"Chua WH, Balakrishnan V, Chan YH, Tong L, Ling Y, Quah BL, et al. Atropine for the treatment of childhood myopia. Ophthalmology. 2006;113(12):2285\u201391.","journal-title":"Ophthalmology"},{"issue":"1","key":"1280_CR98","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2019","unstructured":"Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, et al. Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology. 2019;126(1):113\u201324.","journal-title":"Ophthalmology"},{"issue":"7","key":"1280_CR99","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","volume":"127","author":"JC Yam","year":"2020","unstructured":"Yam JC, Li FF, Zhang X, Tang SM, Yip BHK, Kam KW, et al. Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 2 report. Ophthalmology. 2020;127(7):910\u20139.","journal-title":"Ophthalmology"},{"issue":"3","key":"1280_CR100","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","volume":"129","author":"JC Yam","year":"2022","unstructured":"Yam JC, Zhang XJ, Zhang Y, Wang YM, Tang SM, Li FF, et al. Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report. Ophthalmology. 2022;129(3):308\u201321.","journal-title":"Ophthalmology"},{"issue":"9","key":"1280_CR101","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ophtha.2024.03.013","volume":"131","author":"XJ Zhang","year":"2024","unstructured":"Zhang XJ, Zhang Y, Yip BHK, Kam KW, Tang F, Ling X, et al. Five-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study: phase 4 report. Ophthalmology. 2024;131(9):1011\u201320.","journal-title":"Ophthalmology"},{"issue":"11","key":"1280_CR102","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.tips.2019.09.009","volume":"40","author":"TV Tkatchenko","year":"2019","unstructured":"Tkatchenko TV, Tkatchenko AV. Pharmacogenomic approach to antimyopia drug development: pathways lead the way. Trends Pharmacol Sci. 2019;40(11):833\u201352.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"1280_CR103","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00417-019-04573-y","volume":"258","author":"U Mathis","year":"2019","unstructured":"Mathis U, Feldkaemper M, Wang M, Schaeffel F. Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken. Graefes Arch Clin Exp Ophthalmol. 2019;258(2):319\u201333.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1280_CR104","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2021.12.014","volume":"237","author":"JC Yam","year":"2022","unstructured":"Yam JC, Jiang Y, Lee J, Li S, Zhang Y, Sun W, et al. The association of choroidal thickening by atropine with treatment effects for myopia: two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study. Am J Ophthalmol. 2022;237:130\u20138.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1280_CR105","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.13.4.22","volume":"13","author":"Y Luo","year":"2024","unstructured":"Luo Y, Yin Z, Zhang J, Wang W, Huang Y, Li X, et al. Differential impact of 0.01% and 0.05% atropine eyedrops on ocular surface in young adults. Transl Vis Sci Technol. 2024;13(4):22.","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"1280_CR106","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jama.2022.24162","volume":"329","author":"JC Yam","year":"2023","unstructured":"Yam JC, Zhang XJ, Zhang Y, Yip BHK, Tang F, Wong ES, et al. Effect of low-concentration atropine eyedrops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial. JAMA. 2023;329(6):472\u201381.","journal-title":"JAMA"},{"issue":"10","key":"1280_CR107","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1177\/08853282231166858","volume":"37","author":"Y Fu","year":"2023","unstructured":"Fu Y, Luo Y, Chen X, Tong Y, Zhu Y, Yang L. Atropine-eluting silicone contact lenses for myopia control. J Biomater Appl. 2023;37(10):1724\u201335.","journal-title":"J Biomater Appl"},{"key":"1280_CR108","doi-asserted-by":"publisher","DOI":"10.1116\/6.0003612","author":"D Gao","year":"2024","unstructured":"Gao D, Yan C, Wang Y, Yang H, Liu M, Wang Y, et al. Drug-eluting contact lenses: progress, challenges, and prospects. Biointerphases. 2024. https:\/\/doi.org\/10.1116\/6.0003612.","journal-title":"Biointerphases"},{"issue":"4","key":"1280_CR109","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/09205063.2020.1712175","volume":"31","author":"X Zhang","year":"2020","unstructured":"Zhang X, Cao X, Qi P. Therapeutic contact lenses for ophthalmic drug delivery: major challenges. J Biomater Sci Polym Ed. 2020;31(4):549\u201360.","journal-title":"J Biomater Sci Polym Ed"},{"key":"1280_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114817","volume":"196","author":"TY Kim","year":"2023","unstructured":"Kim TY, Lee G-H, Mun J, Cheong S, Choi I, Kim H, et al. Smart contact lens systems for ocular drug delivery and therapy. Adv Drug Deliv Rev. 2023;196:114817.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"1280_CR111","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11095-024-03672-8","volume":"41","author":"H Yang","year":"2024","unstructured":"Yang H, Zhang F, Fan Y, Zhang J, Fang T, Xing D, et al. Co-delivery of brinzolamide and timolol from micelles-laden contact lenses: in vitro and in vivo evaluation. Pharm Res. 2024;41(3):531\u201346.","journal-title":"Pharm Res"},{"issue":"11","key":"1280_CR112","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s11095-021-03135-4","volume":"38","author":"M Ji","year":"2021","unstructured":"Ji M, Liu H, Ma S, Kong J, Jia Y, Gou J, et al. Stable atropine-loaded film as a potential ocular delivery system for treatment of myopia. Pharm Res. 2021;38(11):1931\u201346.","journal-title":"Pharm Res"},{"key":"1280_CR113","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejpb.2016.09.010","volume":"109","author":"TS Anirudhan","year":"2016","unstructured":"Anirudhan TS, Nair AS, Parvathy J. Extended wear therapeutic contact lens fabricated from timolol imprinted carboxymethyl chitosan-g-hydroxy ethyl methacrylate-g-poly acrylamide as a onetime medication for glaucoma. Eur J Pharm Biopharm. 2016;109:61\u201371.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"1280_CR114","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/OPX.0000000000000807","volume":"93","author":"F Lasowski","year":"2016","unstructured":"Lasowski F, Sheardown H. Atropine and roscovitine release from model silicone hydrogels. Optom Vis Sci. 2016;93(4):404\u201311.","journal-title":"Optom Vis Sci"},{"issue":"5","key":"1280_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2024.102246","volume":"47","author":"M Abdullah Aziz","year":"2024","unstructured":"Abdullah Aziz M, Kuppusamy R, Mazumder K, Hui A, Maulvi F, Stapleton F, et al. Absorption and attachment of atropine to etafilcon A contact lenses. Contact Lens Anterior Eye. 2024;47(5):102246.","journal-title":"Contact Lens Anterior Eye"},{"key":"1280_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2024.101872","volume":"12","author":"AA Abdulamier","year":"2024","unstructured":"Abdulamier AA, Shaker LM, Al-Amiery AA. Advancements in the chemistry of contact lenses: innovations and applications. Results Chem. 2024;12:101872.","journal-title":"Results Chem"},{"key":"1280_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/gels9090684","author":"S Ili\u0107-Stojanovi\u0107","year":"2023","unstructured":"Ili\u0107-Stojanovi\u0107 S, Nikoli\u0107 L, Nikoli\u0107 V, Risti\u0107 I, Caki\u0107 S, Petrovi\u0107 SD. Temperature-sensitive hydrogels as carriers for modulated delivery of acetaminophen. Gels. 2023. https:\/\/doi.org\/10.3390\/gels9090684.","journal-title":"Gels"},{"key":"1280_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2022.113063","volume":"222","author":"M Du","year":"2023","unstructured":"Du M, Jin J, Zhou F, Chen J, Jiang W. Dual drug-loaded hydrogels with pH-responsive and antibacterial activity for skin wound dressing. Colloids Surf, B. 2023;222:113063.","journal-title":"Colloids Surf, B"},{"issue":"5","key":"1280_CR119","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1166\/jbn.2023.3570","volume":"19","author":"Z Wang","year":"2023","unstructured":"Wang Z, Li T, Li X, Wu H, Li Y, Hao L. Preparation of molecularly imprinted hydrogel contact lenses for extended atropine eluting. J Biomed Nanotechnol. 2023;19(5):804\u201313.","journal-title":"J Biomed Nanotechnol"},{"issue":"2","key":"1280_CR120","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/10837450.2021.1999471","volume":"27","author":"H Dang","year":"2022","unstructured":"Dang H, Dong C, Zhang L. Sustained latanoprost release from PEGylated solid lipid nanoparticle-laden soft contact lens to treat glaucoma. Pharm Dev Technol. 2022;27(2):127\u201333.","journal-title":"Pharm Dev Technol"},{"issue":"20","key":"1280_CR121","doi-asserted-by":"publisher","first-page":"11137","DOI":"10.1080\/07391102.2023.2212802","volume":"41","author":"A Banu","year":"2023","unstructured":"Banu A, Naqvi S, Qashqoosh MTA, Manea YK. Multispectroscopic and computational study of interaction of the bovine serum albumin with atropine and atropine-loaded chitosan nanoparticles (synthesized and characterized). J Biomol Struct Dyn. 2023;41(20):11137\u201347.","journal-title":"J Biomol Struct Dyn"},{"key":"1280_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2019.115128","volume":"223","author":"P Gu","year":"2019","unstructured":"Gu P, Wusiman A, Wang S, Zhang Y, Liu Z, Hu Y, et al. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to enhance immune responses. Carbohydr Polym. 2019;223:115128.","journal-title":"Carbohydr Polym"},{"issue":"3","key":"1280_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e42436","volume":"11","author":"DT Pham","year":"2025","unstructured":"Pham DT, Chomchalao P, Bunneramit K, Kladcharoen P, Khotcharrat R, Tiyaboonchai W. Development of sustained-release extemporaneous moxifloxacin-loaded commercial soft hydrogel contact lenses. Heliyon. 2025;11(3):e42436.","journal-title":"Heliyon"},{"issue":"10","key":"1280_CR124","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.4155\/tde.14.73","volume":"5","author":"A ElShaer","year":"2014","unstructured":"ElShaer A, Ghatora B, Mustafa S, Alany RG. Contact lenses as drug reservoirs & delivery systems: the successes & challenges. Ther Deliv. 2014;5(10):1085\u2013100.","journal-title":"Ther Deliv"},{"issue":"3","key":"1280_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2025.102381","volume":"48","author":"MA Aziz","year":"2025","unstructured":"Aziz MA, Maulvi F, Desai DT, Kuppusamy R, Mazumder K, Hui A, et al. Designing a contact lens with atropine base using a microemulsion technique. Cont Lens Anterior Eye. 2025;48(3):102381.","journal-title":"Cont Lens Anterior Eye"},{"issue":"1\u20133","key":"1280_CR126","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.forsciint.2013.04.008","volume":"231","author":"L Meng","year":"2013","unstructured":"Meng L, Meng P, Tang B, Zhang Q, Wang Y. Molecularly imprinted photonic hydrogels for fast screening of atropine in biological samples with high sensitivity. Forensic Sci Int. 2013;231(1\u20133):6\u201312.","journal-title":"Forensic Sci Int"},{"key":"1280_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11070357","author":"N Varga","year":"2019","unstructured":"Varga N, Turcs\u00e1nyi \u00c1, Hornok V, Csap\u00f3 E. Vitamin E-loaded PLA- and PLGA-based core-shell nanoparticles: synthesis, structure optimization and controlled drug release. Pharmaceutics. 2019. https:\/\/doi.org\/10.3390\/pharmaceutics11070357.","journal-title":"Pharmaceutics"},{"key":"1280_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121793","volume":"621","author":"D Chau Thuy Nguyen","year":"2022","unstructured":"Chau Thuy Nguyen D, Dowling J, Ryan R, McLoughlin P, Fitzhenry L. Controlled release of naringenin from soft hydrogel contact lens: an investigation into lens critical properties and in vitro release. Int J Pharm. 2022;621:121793.","journal-title":"Int J Pharm"},{"issue":"35","key":"1280_CR129","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb7878","volume":"6","author":"R Ganugula","year":"2020","unstructured":"Ganugula R, Arora M, Lepiz MA, Niu Y, Mallick BK, Pflugfelder SC, et al. Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation. Sci Adv. 2020;6(35):eabb7878.","journal-title":"Sci Adv"},{"issue":"9","key":"1280_CR130","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1080\/17425247.2020.1788541","volume":"17","author":"S Wang","year":"2020","unstructured":"Wang S, Liu R, Fu Y, Kao WJ. Release mechanisms and applications of drug delivery systems for extended-release. Expert Opin Drug Deliv. 2020;17(9):1289\u2013304.","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"1280_CR131","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/bioengineering11020138","volume":"11","author":"R Shean","year":"2024","unstructured":"Shean R, Yu N, Guntipally S, Nguyen V, He X, Duan S, et al. Advances and challenges in wearable glaucoma diagnostics and therapeutics. Bioengineering. 2024;11(2):138.","journal-title":"Bioengineering"},{"issue":"9","key":"1280_CR132","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.202000152","volume":"20","author":"J Claus","year":"2020","unstructured":"Claus J, Eickner T, Grabow N, Kragl U, Oschatz S. Ion exchange controlled drug release from polymerized ionic liquids. Macromol Biosci. 2020;20(9):e2000152.","journal-title":"Macromol Biosci"},{"issue":"1\u20132","key":"1280_CR133","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijpharm.2017.04.075","volume":"526","author":"Q Bao","year":"2017","unstructured":"Bao Q, Shen J, Jog R, Zhang C, Newman B, Wang Y, et al. In vitro release testing method development for ophthalmic ointments. Int J Pharm. 2017;526(1\u20132):145\u201356.","journal-title":"Int J Pharm"},{"key":"1280_CR134","doi-asserted-by":"crossref","unstructured":"Shariati Pour SR, Oddis S, Barbalinardo M, Ravarino P, Cavallini M, Fiori J, et al. Delivery of active peptides by self-healing, biocompatible and supramolecular hydrogels. Molecules (Basel, Switzerland). 2023;28(6).","DOI":"10.3390\/molecules28062528"},{"issue":"4","key":"1280_CR135","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1007\/s44007-024-00136-8","volume":"3","author":"DM Anderson","year":"2024","unstructured":"Anderson DM, Luke RA. Mathematical models of drug delivery via a contact lens during wear. La Matematica. 2024;3(4):1510\u201364.","journal-title":"La Matematica"},{"key":"1280_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/polym13213703","author":"MUA Khan","year":"2021","unstructured":"Khan MUA, Razaq SIA, Mehboob H, Rehman S, Al-Arjan WS, Amin R. Antibacterial and hemocompatible pH-responsive hydrogel for skin wound healing application. In vitro drug release. Polymers. 2021. https:\/\/doi.org\/10.3390\/polym13213703.","journal-title":"Polymers"},{"key":"1280_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/gels9080645","author":"IS Kurniawansyah","year":"2023","unstructured":"Kurniawansyah IS, Rusdiana T, Sopyan I, Desy Arya IF, Wahab HA, Nurzanah D. Comparative study of in situ gel formulation based on the physico-chemical aspect: systematic review. Gels (Basel Switz). 2023. https:\/\/doi.org\/10.3390\/gels9080645.","journal-title":"Gels (Basel Switz)"},{"key":"1280_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114524","volume":"204","author":"Y Long","year":"2024","unstructured":"Long Y, Hu J, Liu Y, Wu D, Zheng Z, Gui S, et al. Development of puerarin-loaded poly(lactic acid) microspheres for sustained ocular delivery: in vitro\/vivo evaluation. Eur J Pharm Biopharm. 2024;204:114524.","journal-title":"Eur J Pharm Biopharm"},{"issue":"10","key":"1280_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801390","volume":"8","author":"Z Mutlu","year":"2019","unstructured":"Mutlu Z, Shams Es-Haghi S, Cakmak M. Recent trends in advanced contact lenses. Adv Healthc Mater. 2019;8(10):e1801390.","journal-title":"Adv Healthc Mater"},{"issue":"10","key":"1280_CR140","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1007\/s13346-021-01093-3","volume":"12","author":"W Xu","year":"2022","unstructured":"Xu W, Maqbool F, Kumar V, Falconer JR, Cui CS, Woodruff TM, et al. Sustained-release ketamine-loaded lipid-particulate system: in vivo assessment in mice. Drug Deliv Transl Res. 2022;12(10):2518\u201326.","journal-title":"Drug Deliv Transl Res"},{"key":"1280_CR141","doi-asserted-by":"publisher","first-page":"9055","DOI":"10.2147\/IJN.S477248","volume":"19","author":"F Yang","year":"2024","unstructured":"Yang F, Dong Q, Chen Z, Gao B, Zheng D, Wang R, et al. A pH-responsive drug-delivery system based on apatinib-loaded metal-organic frameworks for ferroptosis-targeted synergistic anti-tumor therapy. Int J Nanomed. 2024;19:9055\u201370.","journal-title":"Int J Nanomed"},{"key":"1280_CR142","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jconrel.2023.11.016","volume":"365","author":"Y Cai","year":"2024","unstructured":"Cai Y, Xin L, Li H, Sun P, Liu C, Fang L. Mussel-inspired controllable drug release hydrogel for transdermal drug delivery: hydrogen bond and ion-dipole interactions. J Control Release. 2024;365:161\u201375.","journal-title":"J Control Release"},{"key":"1280_CR143","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jcis.2016.03.034","volume":"473","author":"SH Khan","year":"2016","unstructured":"Khan SH, Hoffmann PM. Young\u2019s modulus of nanoconfined liquids? J Colloid Interface Sci. 2016;473:93\u20139.","journal-title":"J Colloid Interface Sci"},{"issue":"Pt A","key":"1280_CR144","doi-asserted-by":"publisher","first-page":"124908","DOI":"10.1016\/j.ijpharm.2024.124908","volume":"667","author":"J Teixeira","year":"2024","unstructured":"Teixeira J, Lumack Monte Z, Tenreiro S, Salema-Oom M, Silva DC, Saramago B, et al. Citicoline\u2013eluting hydrogels for therapeutic contact lenses intended to treat neurodegenerative diabetic ocular diseases. Int J Pharm. 2024;667(Pt A):124908.","journal-title":"Int J Pharm"},{"key":"1280_CR145","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12040360","author":"PL Destruel","year":"2020","unstructured":"Destruel PL, Zeng N, Brignole-Baudouin F, Douat S, Seguin J, Olivier E, et al. In situ gelling ophthalmic drug delivery system for the optimization of diagnostic and preoperative mydriasis. In vitro drug release, cytotoxicity and mydriasis pharmacodynamics. Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics12040360.","journal-title":"Pharmaceutics"},{"key":"1280_CR146","volume":"5","author":"SF Elhabal","year":"2023","unstructured":"Elhabal SF, Ghaffar SA, Hager R, Elzohairy NA, Khalifa MM, Mohie PM, et al. Development of thermosensitive hydrogel of amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections: in-vitro, ex-vivo and in-vivo studies. Int J Pharm X. 2023;5:100174.","journal-title":"Int J Pharm X"},{"issue":"2","key":"1280_CR147","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1167\/iovs.06-1007","volume":"48","author":"L Wang","year":"2007","unstructured":"Wang L, Lu L. Pathway-specific effect of caffeine on protection against UV irradiation-induced apoptosis in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2007;48(2):652\u201360.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1280_CR148","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jconrel.2022.02.014","volume":"343","author":"AF Pereira-da-Mota","year":"2022","unstructured":"Pereira-da-Mota AF, Phan C-M, Concheiro A, Jones L, Alvarez-Lorenzo C. Testing drug release from medicated contact lenses: the missing link to predict in vivo performance. J Control Release. 2022;343:672\u2013702.","journal-title":"J Control Release"},{"key":"1280_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1358046","volume":"11","author":"B Li","year":"2024","unstructured":"Li B, Yu S, Gao S, Sun G, Pang X, Li X, et al. Effect of 0.01% atropine combined with orthokeratology lens on axial elongation: a 2-year randomized, double-masked, placebo-controlled, cross-over trial. Front Med. 2024;11:1358046.","journal-title":"Front Med"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01280-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:02:53Z","timestamp":1770454973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01280-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01280-2","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yuhang Liu, Xiaohang Chen, Chenhao Zhu, Dong Wang, Aimin Zhang and Longqian Liu declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}